Literature DB >> 33793198

Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42.

Sheng Zhang1, Gretchen Guaglianone1, Michael A Morris1, Stan Yoo1, William J Howitz1, Li Xing2, Jian-Guo Zheng2, Hannah Jusuf1, Grace Huizar1, Jonathan Lin1, Adam G Kreutzer1, James S Nowick1,3.   

Abstract

Fluorescent derivatives of the β-amyloid peptides (Aβ) are valuable tools for studying the interactions of Aβ with cells. Facile access to labeled expressed Aβ offers the promise of Aβ with greater sequence and stereochemical integrity, without impurities from amino acid deletion and epimerization. Here, we report methods for the expression of Aβ42 with an N-terminal cysteine residue, Aβ(C1-42), and its conjugation to generate Aβ42 bearing fluorophores or biotin. The methods rely on the hitherto unrecognized observation that expression of the Aβ(MC1-42) gene yields the Aβ(C1-42) peptide, because the N-terminal methionine is endogenously excised by Escherichia coli. Conjugation of Aβ(C1-42) with maleimide-functionalized fluorophores or biotin affords the N-terminally labeled Aβ42. The expression affords ∼14 mg of N-terminal cysteine Aβ from 1 L of bacterial culture. Subsequent conjugation affords ∼3 mg of labeled Aβ from 1 L of bacterial culture with minimal cost for labeling reagents. High-performance liquid chromatography analysis indicates the N-terminal cysteine Aβ to be >97% pure and labeled Aβ peptides to be 94-97% pure. Biophysical studies show that the labeled Aβ peptides behave like unlabeled Aβ and suggest that labeling of the N-terminus does not substantially alter the properties of the Aβ. We further demonstrate applications of the fluorophore-labeled Aβ peptides by using fluorescence microscopy to visualize their interactions with mammalian cells and bacteria. We anticipate that these methods will provide researchers convenient access to useful N-terminally labeled Aβ, as well as Aβ with an N-terminal cysteine that enables further functionalization.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33793198      PMCID: PMC9059633          DOI: 10.1021/acs.biochem.1c00105

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.321


  65 in total

Review 1.  Related impurities in peptide medicines.

Authors:  Matthias D'Hondt; Nathalie Bracke; Lien Taevernier; Bert Gevaert; Frederick Verbeke; Evelien Wynendaele; Bart De Spiegeleer
Journal:  J Pharm Biomed Anal       Date:  2014-06-13       Impact factor: 3.935

2.  Chirality Dependence of Amyloid β Cellular Uptake and a New Mechanistic Perspective.

Authors:  Subrata Dutta; Thomas S Finn; Ariel J Kuhn; Benjamin Abrams; Jevgenij A Raskatov
Journal:  Chembiochem       Date:  2019-02-27       Impact factor: 3.164

3.  Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.

Authors:  Peter M Clifford; Shabnam Zarrabi; Gilbert Siu; Kristin J Kinsler; Mary C Kosciuk; Venkateswar Venkataraman; Michael R D'Andrea; Steven Dinsmore; Robert G Nagele
Journal:  Brain Res       Date:  2007-01-27       Impact factor: 3.252

4.  Internalization of beta-amyloid peptide by primary neurons in the absence of apolipoprotein E.

Authors:  Lucila Saavedra; Amany Mohamed; Victoria Ma; Satyabrata Kar; Elena Posse de Chaves
Journal:  J Biol Chem       Date:  2007-10-02       Impact factor: 5.157

5.  Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells.

Authors:  Saravanapavan Parvathy; Jayakumar Rajadas; Heather Ryan; Sepideh Vaziri; Laurel Anderson; Greer M Murphy
Journal:  Neurobiol Aging       Date:  2008-03-12       Impact factor: 4.673

6.  Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome.

Authors:  Christian Arriagada; Miguel Bustamante; Illani Atwater; Eduardo Rojas; Raúl Caviedes; Pablo Caviedes
Journal:  Neurosci Lett       Date:  2009-12-30       Impact factor: 3.046

7.  A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.

Authors:  Hyung Jin Ahn; J Fraser Glickman; Ka Lai Poon; Daria Zamolodchikov; Odella C Jno-Charles; Erin H Norris; Sidney Strickland
Journal:  J Exp Med       Date:  2014-05-12       Impact factor: 14.307

8.  Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer's Disease?

Authors:  Christopher J Dunning; Gavin McGauran; Katarina Willén; Gunnar K Gouras; David J O'Connell; Sara Linse
Journal:  ACS Chem Neurosci       Date:  2015-12-15       Impact factor: 4.418

9.  Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells.

Authors:  Amberley D Stephens; Meng Lu; Ana Fernandez-Villegas; Gabriele S Kaminski Schierle
Journal:  ACS Chem Neurosci       Date:  2020-10-02       Impact factor: 4.418

10.  ApoE promotes the proteolytic degradation of Abeta.

Authors:  Qingguang Jiang; C Y Daniel Lee; Shweta Mandrekar; Brandy Wilkinson; Paige Cramer; Noam Zelcer; Karen Mann; Bruce Lamb; Timothy M Willson; Jon L Collins; Jill C Richardson; Jonathan D Smith; Thomas A Comery; David Riddell; David M Holtzman; Peter Tontonoz; Gary E Landreth
Journal:  Neuron       Date:  2008-06-12       Impact factor: 17.173

View more
  2 in total

1.  A Disulfide-Stabilized Aβ that Forms Dimers but Does Not Form Fibrils.

Authors:  Sheng Zhang; Stan Yoo; Dalton T Snyder; Benjamin B Katz; Amy Henrickson; Borries Demeler; Vicki H Wysocki; Adam G Kreutzer; James S Nowick
Journal:  Biochemistry       Date:  2022-01-26       Impact factor: 3.321

2.  Elucidating the Oligomerization and Cellular Interactions of a Trimer Derived from Aβ through Fluorescence and Mass Spectrometric Studies.

Authors:  Gretchen Guaglianone; Belén Torrado; Yu-Fu Lin; Matthew C Watkins; Vicki H Wysocki; Enrico Gratton; James S Nowick
Journal:  ACS Chem Neurosci       Date:  2022-07-27       Impact factor: 5.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.